Database Query Results : Anzaroot, Astragalus fasciculifolius Bioss, ,

Anzaroot, Anzaroot, Astragalus fasciculifolius Bioss: Click to Expand ⟱
Features:
Anzaroot, Astragalus fasciculifolius Bioss : (the traditional gum/resin from Astragalus sarcocolla, also written “sarcocolla” or “sarcocolla gum”) is a complex natural product whose main bioactive classes are — polysaccharides (gum carbohydrates), flavonoids/phenolics, and triterpene saponins (including astragaloside-type saponins in the broader Astragalus genus
-extracts or Anzaroot-mediated silver nanoparticles have shown cytotoxic effects on cancer cell lines; the proposed anticancer mechanisms are apoptosis induction, ROS generation, cell-cycle arrest and immunomodulation via NF-κB / PI3K-Akt / MAPK and caspase pathways.

Anzaroot — a traditional Persian/West Asian oleo-gum-resin (“sarcocolla gum”) exudate sourced from certain Astragalus species (taxonomy in the literature is variable; products are often discussed under “sarcocolla/anzaroot”). It is a complex botanical material dominated by hydrophilic gum polysaccharides (high–molecular weight carbohydrate polymers), with variable minor fractions of phenolics/flavonoids and other small molecules depending on species and processing. Formal classification: complex natural product (plant gum/resin; typically used as crude powder, aqueous extract, or topical gel). Standard abbreviation(s): none standardized; sometimes referenced as “sarcocolla gum” or “Anzaroot extract” in studies.

Primary mechanisms (ranked):

  1. Barrier and tissue-response modulation in topical use contexts (hydrating/film-forming polysaccharides; context-dependent inflammation and wound-repair signaling)
  2. Immuno-inflammatory modulation (context-dependent; preparation-dependent)
  3. Redox modulation (ROS↔; antioxidant/pro-oxidant balance is preparation- and concentration-dependent; not reliably cytotoxic without an added trigger)
  4. Phenotype-level antiproliferative signaling in cancer cells (model-dependent; typically requires high in-vitro concentrations if present and is often not mechanistically resolved)

Bioavailability / PK relevance: Systemic bioavailability of the dominant high–molecular weight polysaccharide fraction is expected to be low with oral dosing (primarily local GI exposure unless specially formulated). Most human-use literature is topical; systemic PK parameters for defined active constituents are not established.

In-vitro vs systemic exposure relevance: Any reported direct anticancer effects of crude Anzaroot extracts in vitro (when present) may occur at concentrations that exceed achievable systemic exposure from typical oral use, and the active fraction(s) are usually not chemically standardized. Topical exposure is locally high but not directly comparable to systemic anticancer relevance.

Clinical evidence status: Cancer: preclinical/limited in-vitro only and not clinically established. Non-cancer: small human trials exist for topical Anzaroot gel in wound/pain contexts (e.g., postpartum episiotomy), supporting local symptomatic benefit rather than anticancer efficacy.

Mechanistic pathway ranking for Anzaroot gum / aqueous extract only (excluding AgNPs)

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Clinical Translation Constraint Exposure feasibility↔ (context-dependent) Generally well-tolerated topically; systemic relevance↔ G Limits interpretation of “anticancer” claims As a high–molecular weight gum/resin mixture, systemic bioavailability is expected to be low; anticancer translation without a delivery strategy is uncertain.
2 Inflammation and wound-repair signaling Tumor-promoting inflammation↓ (context-dependent) Tissue repair support↑ (context-dependent) G Microenvironment modulation Better supported for topical use contexts than oncology; could be relevant only indirectly via tumor microenvironment models.
3 ROS and redox stress ROS↔ (dose-dependent) ROS↔ (context-dependent) P/R Contextual redox modulation Without AgNPs, strong ROS-driven cytotoxicity is not a safe assumption; any antioxidant/pro-oxidant direction is preparation- and concentration-dependent.
4 Cell-cycle control and proliferation state Proliferation↓ (model-dependent) Minimal direct effect expected (context-dependent) G Possible growth suppression If any direct antiproliferative activity exists, it likely requires higher in-vitro concentrations; mechanism typically not well-resolved without targeted assays.
5 Apoptosis signaling Apoptosis↑ (model-dependent) Unclear R/G Stress-linked cell death (possible) For “extract only,” apoptosis should be treated as a possible downstream phenotype rather than a defined primary pathway unless directly demonstrated.

TSF legend: P: 0–30 min   R: 30 min–3 hr   G: >3 hr

************************************************************************************************

Anzaroot plus AgNPs — a traditional Persian/West Asian oleo-gum-resin (“sarcocolla gum”) exudate sourced from certain Astragalus species (notably Astragalus fasciculifolius Boiss. in the Nestronics entry; “sarcocolla” is also historically tied to A. sarcocolla). It is a complex botanical material dominated by hydrophilic gum polysaccharides (high–molecular weight carbohydrate polymers) with variable contributions from phenolics/flavonoids and triterpene saponin-like constituents depending on species and processing. Formal classification: complex natural product (plant gum/resin extract); frequently studied as an aqueous extract and as a “green synthesis” reducing/capping matrix for silver nanoparticles (AgNPs).

Primary mechanisms (ranked):

  1. AgNP-associated intracellular oxidative stress with ROS↑ leading to macromolecular damage and stress signaling (context: “green-synthesized” Anzaroot-derived AgNPs in vitro)
  2. DNA damage/stress-response signaling with p53 axis engagement and downstream apoptosis programs (model-dependent; often framed as ROS→p53 coupling for AgNP cytotoxicity)
  3. Anti-proliferative phenotype in cancer cells including cell-cycle disruption/arrest (context-dependent; largely inferred from growth inhibition endpoints unless explicitly measured)
  4. Membrane interaction/uptake effects that increase intracellular delivery of AgNP payload and perturb membrane integrity (nanoparticle size/coating-dependent)

Bioavailability / PK relevance: As a gum/resin mixture, systemic bioavailability of the high–molecular weight polysaccharide fraction is expected to be low orally (primarily local GI exposure unless formulated/processed). Human use in the literature is predominantly topical (e.g., gel formulations). Anticancer work in vitro (MCF-7) using Anzaroot-derived AgNPs and aqueous extracts; systemic PK for these specific preparations is not established.

In-vitro vs systemic exposure relevance: The most directly supported anticancer signal here is concentration-dependent cytotoxicity of Anzaroot-derived AgNPs in cell culture (tens of µg/mL range in the linked study). Achievability and safety of comparable systemic exposures in humans are uncertain; AgNP biodistribution and toxicity are strongly size/coating/dose/route-dependent, and “colloidal silver” ingestion is associated with clinically recognized risks (e.g., argyria) in inappropriate use contexts.

Clinical evidence status: Cancer: preclinical/in-vitro only for Anzaroot-derived AgNP cytotoxicity in the Nestronics-linked record. Non-cancer: small human RCT evidence exists for topical Anzaroot gel in postpartum episiotomy pain and for a related traditional preparation in anal fissure, but these do not establish anticancer efficacy.

Mechanistic pathway ranking for Anzaroot-derived AgNP preparations in cancer models

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Intracellular ROS and oxidative stress ROS↑ → oxidative stress↑ (dose-dependent) Unclear (likely context-dependent) P/R Trigger stress-mediated cytotoxicity Directly described for Anzaroot-derived AgNPs in MCF-7; magnitude depends on particle size/coating and dosing.
2 DNA damage response and p53 axis p53 signaling↑ (model-dependent) Unclear R Enable apoptosis programs under stress Presented mechanistically as ROS-coupled p53-mediated apoptosis for AgNP cytotoxicity; specific tumor genotype will modulate outcomes.
3 Cell-cycle control and proliferation state Proliferation↓; cell-cycle disruption↑ (context-dependent) Unclear G Growth inhibition Nestronics tags include tumor cell-growth suppression; the linked paper primarily supports growth inhibition via MTT across 24–72 h, not a fully mapped checkpoint mechanism.
4 Membrane interaction and cellular uptake Membrane perturbation↑; uptake↑ (particle-dependent) Unclear P/R Improve intracellular delivery; contribute to toxicity Common AgNP mechanism: surface-to-volume ratio and endocytosis-driven entry; may couple to ROS generation and organelle stress.
5 Drug resistance and selectivity heuristics Apparent efficacy↑; selectivity↑ (model-dependent) Not established G Potential therapeutic window signals These are Nestronics tags; the single linked study does not comprehensively profile normal-cell selectivity or transporter-mediated resistance.
6 Clinical Translation Constraint Exposure feasibility↔; safety-limited (context-dependent) Safety-limited (context-dependent) G Limits systemic translation Evidence base here is in vitro for cancer; human data are topical/non-cancer. AgNP systemic use is constrained by biodistribution/toxicity uncertainties and silver accumulation risks.

TSF legend: P: 0–30 min   R: 30 min–3 hr   G: >3 hr
Scientific Papers found: Click to Expand⟱
4413- AgNPs,  Anzaroot,    Green synthesis of silver nanoparticles from plant Astragalus fasciculifolius Bioss and evaluating cytotoxic effects on MCF7 human breast cancer cells
- in-vitro, BC, MCF-7
chemoP↑, TumCG↓, eff↑, CellMemb↑, selectivity↑, ROS↑, P53↑,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

ROS↑, 1,  

DNA Damage & Repair ⓘ

P53↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

TumCG↓, 1,  

Barriers & Transport ⓘ

CellMemb↑, 1,  

Drug Metabolism & Resistance ⓘ

eff↑, 1,   selectivity↑, 1,  

Functional Outcomes ⓘ

chemoP↑, 1,  
Total Targets: 7

Pathway results for Effect on Normal Cells:


Total Targets: 0

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:370  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page